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Background: Helicobacter pylori (HP) and Epstein-Barr virus (EBV) have been associated with cancer development.
We evaluated the prevalence of HP, HP CagA+ and EBV infection in gastric cancer (GC) samples from adults and in
gastric tissues from patients who underwent upper endoscopy (UE).
Methods: Samples from UE and GC were collected to investigate the presence of HP infection and the HP
virulence factor CagA by a urease test and PCR. The presence of EBV was detected by Eber-1 in situ hybridization.
Results: In UE, 85.5% of juvenile patients showed some degree of gastritis (45.3% of patients with mild gastritis and
54.7% with moderate/severe gastritis) and patients with mild gastritis were younger than patients with moderate/
severe gastritis. Among adults, 48.7% presented mild gastritis and 51.3% moderate/severe gastritis. HP infection was
detected in 0% of normal mucosa, 58.5% of juvenile gastritis patients, 69.2% of adult gastritis patients and 88% of GC
patients. In these same groups, HP CagA+ was detected in 0%, 37.7%, 61.5% and 67.2% of tissue samples, respectively.
In juvenile patients, HP infection was more common in those with gastritis than in normal samples (p = 0.004). The
patients with either HP or HP CagA+ were older than patients without these pathogens (p < 0.05). In juvenile patients,
HP infection was more frequent in cases of moderate/severe gastritis than in cases of mild gastritis (p = 0.026).
Moreover, in patients with GC, HP infection was more frequent in males than in females (p = 0.023). GC patients with
HP CagA+ were older than patients with HP CagA- (p = 0.027). HP CagA+ was more common in intestinal-type than
diffuse-type GC (p = 0.012). HP CagA+ was also associated with lymph-node (p = 0.024) and distal (p = 0.005) metastasis.
No association between EBV infection and HP infection or any clinicopathological variable was detected.
Conclusions: Our results suggest that HP is involved in the pathophysiology of severe gastric lesions and in the
development of GC, particularly when CagA+ is present. EBV was not the primary pathogenic factor in our samples.
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Gastric cancer (GC) and other gastrointestinal diseases
occur at high rates worldwide [1], and infections involv-
ing viruses and bacteria have been associated with these
diseases. Recently, several studies have been performed
to understand the role of pathogens that infect the hu-
man stomach, particularly Helicobacter pylori (HP) and
Epstein-Barr virus (EBV), in gastric carcinogenesis [2-5].
HP, a Gram-negative spiral bacterium, is considered a
public health problem. In 1994, the International Agency
for Research on Cancer (IARC) defined HP as a group 1
carcinogen [6,7]. This bacterium colonizes the gastric
mucosa of more than 50% of the world’s population [8].
However, only approximately 20% of infected individuals
develop severe gastric diseases such as GC. Among the
factors- that have been suggested to contribute to devel-
opment of gastric disease in HP-infected patients are the
virulence of HP strains, the permissiveness of the gastric
environment and the host genetic background [9]. The
HP cytotoxicity associated gene A (CagA) is one of the
most significant virulence factors of this bacteria, and it
has been associated with risk for GC [10].
EBV infects more than 90% of the global adult popula-
tion, and most individuals are infected during childhood.
Upon infection, the virus remains latent in B lympho-
cytes throughout life [5]. To be oncogenic, EBV must
maintain its genome inside host cells to avoid cell death
and to evade recognition by the immune system. The
contribution of EBV to gastric carcinogenesis has not
been fully elucidated [11,12]. EBV infects epithelial cells
from the oropharynx and subsequently spreads to the
lymphoid tissues where it infects B lymphocytes [13-15].
Atrophic gastritis may induce the infiltration of EBV-
carrying lymphocytes and increase the chance of their
contact with the gastric epithelial cells. On the other hand,
the gastric inflammation may also produce a cytokine-rich
microenvironment to support clonal growth of EBV-
infected epithelial cells [16].
In developing countries such as Brazil, HP and EBV
infections are particularly prevalent within lower socio-
economic populations. Furthermore, infection occurs at
earlier ages in these populations compared to developed
countries [17-19]. Studies are needed to determine these
pathogens’ association with and influence on the devel-
opment of gastric diseases at earlier ages, where they
could initiate or promote carcinogenic processes. Add-
itionally, the role of HP and EBV in the development of
gastric adenocarcinoma in the elderly, the population
where this disease is most prevalent, remains unclear.
Therefore, this study aimed to assess the prevalence of
HP and EBV infection, as well as the CagA-positive
status of HP, in gastric tissues from juvenile and adult
patients undergoing upper endoscopy (UE) and in tumor
specimens from adult patients with GC.Methods
Samples
The present study included: (i) gastric tissue samples from
62 juvenile patients ranging from 12 months to 18 years
old, referred for UE to clarify clinical manifestations
within the upper gastrointestinal tract, (ii) gastric tissue
samples from 39 adult patients ranging from 19 to 61 years
old, referred for UE to clarify clinical manifestations
within the upper gastrointestinal tract, and (iii) tumor
samples from 125 adults, 26 to 89 years old, with primary
gastric adenocarcinoma. Samples were randomly collected
during the period of 2005-2013 in Belém city of Pará
State, Northern Brazil. Informed consent was obtained
prior to sample collection from all adult patients or from
the parents or guardians of all juvenile patients. Sample
collection was carried out with the approval of the eth-
ics committee of the Human Institute of Health Sci-
ences of the Federal University of Pará (Protocol #35/
2010) and João de Barros Barreto University Hospital
(Protocol #142004). All patients had negative histories
of exposure to chemotherapy and radiotherapy prior to
sample collection, and no patient presented with co-
occurrence of diagnosed cancers. Data on the clinical fea-
tures of patients were collected from medical records.Histopathology
Endoscopic findings were classified according to the
updated Sydney System [20] which considers the degree
of inflammation, activity, atrophy and intestinal meta-
plasia. For each patient, 5 biopsies of gastric tissues
were evaluated: 2 from the antral region of the stom-
ach, 1 from the incisura angularis, and 2 from the ox-
yntic mucosa. Chronic gastritis was designated as mild,
moderate or severe.
Gastric tumors were classified according to the Lauren
classification [21] and staged using standard criteria by
pTNM staging [22]. Tables 1 and 2 show the clinicopatho-
logical features of gastritis and GC samples, respectively.HP and CagA detection
The presence of HP was detected by a commercially
available rapid urease test (Promedical, Brazil), and the
negative results were confirmed by PCR using the oligo-
nucleotides described by Covacci et al. [23]. All gastric
samples were placed in a tube containing 2% Christensen’s
urea agar and examined for urea hydrolysis after 24 h of
incubation at 37°C. In the presence of urease produced by
HP, the urea is converted to ammonia, resulting in a
change of pH and, consequently, the color of the solution.
The detection of the CagA gene was carried out by PCR
in the gastric mucosa of all patients, using the oligonucle-
otides described by Covacci et al. [23]. All reactions were
performed in duplicate. A sample was considered positive
Table 1 Clinicopathological features, H. pylori and EBV infection in gastritis samples of juvenile patients
Variable H. pylori CagA EBV
Negative Positive p-value Negativec Positive p-value Negative Positive p-value
Age (years, Mean ± SD) 7.45 ± 3.88 12.19 ± 4.09 <0.001* 8.88 ± 4.49 12.45 ± 4.01 0.005* 9.96 ± 4.5 17 ± 1.41 0.033*
Gender [N(%)]
Female 14 (42.4) 19 (57.6) 0.685a 23 (69.7) 10 (30.3) 0.096a 32 (97.0) 1 (3.0) 0.626a
Male 8 (40.0) 12 (60.0) 10 (50.0) 10 (50.0) 19 (95.0) 1 (5.0)
Histological subtype [N(%)]
Mild 16 (66.7) 8 (33.3) 0.026*b 20 (83.3) 4 (16.7) 0.108b 23 (95.8) 1 (4.2) 0.136b
Moderate/Severe 6 (20.7) 23 (79.3) 13 (44.8) 16 (55.2) 28 (96.6) 1 (3.4)
EBV infection [N(%)]
Absent 21 (41.2) 30 (58.8) 0.242b 31 (60.8) 20 (39.2) 0.998b
Present 1 (50) 1 (50) 2 (100) 0 (0)
*Significant difference between groups, p < 0.05. ap value after adjustment for age; bp value after adjustment for age and gender; cNegative samples for H. pylori
and samples with H. pylori infection but without CagA virulence factor; EBV: Epstein-Barr virus; SD: standard deviation.
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electrophoresis gel.
EBV detection
EBV was detected by RNA in situ hybridization (ISH)
with a 30-bp biotinylated probe (5’-AGACACCGTC
CTCACCACCCGGGACTTGTA-3’) complementary to
EBV-encoded small RNA-1 (Eber1), the most abundant
viral product in latently infected cells [24]. Signal ampli-
fication was achieved with a mouse anti-biotin antibody
(clone BK, 1:20 dilution; DakoCytomation®, CA, USA)
and biotinylated rabbit anti-immunoglobulin antibody
(polyclonal, 1:100 dilution; DakoCytomation®, CA, USA).
The reaction was detected with streptavidin-biotin perox-
idase complex (DakoCytomation®, CA, USA) and diamino-
benzidine chromogen (DakoCytomation®, CA, USA). The
slides were counterstained with Harris’s hematoxylin. Cell
analysis was performed by 2 independent investigatorsTable 2 Clinicopathological features, H. pylori and EBV infecti
Variable H. pylori
Negative Positive p-value Neg
Age (Mean ± SD) 35.58 ± 7.82 45.00 ± 10.89 0.011* 37.6
Gender [N(%)]
Female 3 (21.4) 11 (78.6) 0.410a 5 (
Male 9 (36.0) 16 (64.0) 10
Histological subtype [N(%)]
Mild 7 (36.8) 12 (63.2) 0.715b 9 (
Moderate/Severe 5 (25.0) 15 (75.0) 6 (
EBV infection [N(%)]
Absent 12 (32.4) 25 (67.6) 0.999b 14
Present 0 (0) 2 (100) 1 (
*Significant difference between groups, p < 0.05. ap value after adjustment for age;
and samples with H. pylori infection but without CagA virulence factor; EBV: Epsteinusing light microscopy, at 40x or 20x magnification. A total
of 10 representative microscopic fields were evaluated, and
fields containing less than 5 cells were not considered. A
gastric cancer sample positive for EBV was included as a
positive control, and two slides treated without probe were
used as negative controls. Samples where 5% or more of
the epithelial cells contained brown/red staining were con-
sidered positive. Although lymphocytes were also found to
be infected by EBV, we did not include infected lymphoid
cells in our analysis.
Statistical analyses
The Shapiro-Wilk test was used to evaluate the distri-
bution of age data and to determine the appropriate
subsequent test for statistical comparison. The Mann-
Whitney test (non-parametric) or T-test for independ-
ent samples (parametric) was used to compare ages
between the groups. Associations between HP or EBVon in gastritis samples of adults patients
CagA EBV
ativec Positive p-value Negative Positive p-value
± 7.67 44.92 ± 11.75 0.039* 42.24 ± 11.14 39.50 ± 3.54 0.733
35.7) 9 (64.3) 0.915a 14 (100) 0 (0) 0.999a
(40.0) 15 (60.0) 23 (92.0) 2 (8.0)
47.4) 10 (52.6) 0.820b 17 (89.5) 2 (10.5) 0.999b
30.0) 14 (70.0) 20 (100) 0 (0)
(37.8) 23 (62.2) 0.810b
50.0) 1 (50.0)
bp value after adjustment for age and gender; cNegative samples for H. pylori
-Barr virus; SD: standard deviation.
de Souza et al. BMC Gastroenterology 2014, 14:179 Page 4 of 9
http://www.biomedcentral.com/1471-230X/14/179and other clinicopathological features were analyzed
using chi-square (χ2) and logistic regression. A p-value
less than 0.05 was considered significant, and the confi-
dence interval was 95%.
Results
We investigated 226 individuals, including 92 women and
134 men, divided into three groups. The percentage of men
was 38.7%, 64.1% and 68% for juvenile UE patients, adult
UE patients and GC patients, respectively. The proportion
of males was higher in the cohort of GC patients (p < 0.001,
OR = 3.365, 95% CI = 1.784 – 6.345) and adult UE patients
(p = 0.014, OR = 2.827, 95% CI = 1.233 – 6.485) than among
juvenile UE patients.
Among juvenile UE patients, 40 patients presented
gastritis by UE. However, 59% of patients without UE-
diagnosed gastritis presented mild gastritis by histo-
pathological analysis. Therefore, 53 (85.5%) patients
showed some degree of gastritis in the group of juvenile UE
patients. The age of patients without gastritis did not differ
from that of patients with gastritis [median ± interquartile
range (IQR): 7.33 ± 8 vs 10.23 ± 8 years old; p = 0.080,
Mann-Whitney test]. However, patients with mild gastritis
were younger than patients with moderate or severe
gastritis (mean ± standard deviation (SD): 8.25 ± 4.30.90
vs 11.86 ± 4.27 years old; p = 0.004, T-test). The gender
breakdown did not differ between juvenile patients with
and without gastritis (p = 0.725), as well as between
juvenile patients with mild gastritis and moderate or
severe gastritis (p = 0.097).
Among adult UE patients, all of the evaluated individ-
uals presented gastritis, including 19 (48.7%) with mild
gastritis and 20 (51.3%) with moderate or severe gastritis.
Patients with mild gastritis were younger than patients
with moderate or severe gastritis (mean ± SD: 37.47 ± 7.20
vs 46.50 ± 12.07 years old; p = 0.003, T-test). The gender
breakdown did not differ between juveniles patients withFigure 1 Pathogen frequency in normal gastric mucosa, gastritis of ju
infection. B) CagA virulence factor of HP. C) EBV infection. *Significant diffe
and gender (p < 0.05).mild gastritis and moderate or severe gastritis (p = 1) in
this group of analysis.
HP infection was detected in 0% of normal gastric mu-
cosa samples, 58.5% of samples from juvenile gastritis
patients, 69.2% of adult gastritis samples and 88% of GC
patients (Figure 1a). In juvenile individuals, HP infection
was more frequently observed in gastritis samples than in
normal samples (p = 0.004, Yates correction). The fre-
quency of HP in adult gastritis did not differ from the ob-
served frequency of gastritis in juvenile patients (p = 1.000,
after adjustment for age and gender) or in the GC samples
(p = 0.335, after adjustment for age and gender).
HP CagA+ was detected in 0% of normal gastric mucosa
samples, 37.7% of samples from juvenile gastritis patients,
61.5% of adult gastritis samples and 67.2% of GC patients
(Figure 1b). The frequency of infection by HP CagA+ did
not differ between samples from juvenile patients with
gastritis and normal gastric mucosa (p = 0.064, Yates cor-
recton). Moreover, the frequency of HP CagA+ in adult
gastritis tissue samples did not differ from that observed
in juvenile gastritis patients (p = 1, after adjustment for
age and gender) or in GC samples (p = 0.500, after adjust-
ment for age and gender).
The frequency of HP infection did not differ between
males and females in the samples from juvenile or adult
patients evaluated by UE (p > 0.05, after adjustment for
age; Tables 1 and 2). However, in GC samples, HP infec-
tion was detected more frequently in males than in
females (p = 0.023 OR = 3.651, 95% CI = 1.190 – 11.199,
after adjustment for age; Table 3).
In juvenile patients who underwent UE, gastritis pa-
tients with HP infection and with HP CagA+ were older
than those without this pathogen (p < 0.001 and p = 0.005,
respectively, T-test; Table 1). In this group of patients,
HP infection was more prevalent in cases of moderate
or severe gastritis than in those of mild gastritis (p = 0.026;
OR = 5.136, 95% CI = 1.220 – 21.611, after adjustment forveniles, gastritis of adults and gastric cancer samples. A) H. pylori
rence between groups by logistic regression, after adjustment for age
Table 3 Clinicopathological features, H. pylori and EBV infection in gastric tumors
Variable H. pylori CagA EBV
Negative Positive p-value Negativec Positive p-value Negative Positive p-value
Age (Median ± IQR) 57 ± 25 64 ± 16.75 0.027* 57 ± 22 64.5 ± 16.5 0.027* 63 ± 20 67 ± 21.5 0.192
Gender [N(%)]
Female 9 (22.5) 31 (77.5) 0.023*a 15 (37.5) 25 (62.5) 0.307a 39 (97.5) 1 (2.5) 0.115a
Male 6 (7.1) 79 (92.9) 26 (30.6) 59 (69.4) 74 (87.1) 11 (12.9)
Tumor location [N(%)]
Non-cardia 12 (16.4) 61 (83.6) 0.080b 26 (35.6) 47 (64.4) 0.519b 67 (91.8) 6 (8.2) 0.592b
Cardia 3 (5.8) 49 (94.2) 15 (28.8) 37 (71.2) 46 (88.5) 6 (11.5)
Histological subtype [N(%)]
Intestinal-type 6 (8.5) 65 (91.5) 0.247b 25 (46.3) 29 (53.7) 0.012*b 63(88.7) 8 (11.3) 0.650b
Diffuse-type 9 (16.7) 45 (83.3) 16 (22.5) 55 (77.5) 50 (92.6 4 (7.4)
Stage [N(%)]
Early 7 (15.9) 37 (84.1) 0.680b 25 (56.8) 19 (43.2) 0.000*b 41 (93.2) 3 (6.8) 0.999b
Advanced 6 (8.3) 66 (91.7) 14 (19.4) 58 (80.6) 64 (88.9) 8 (11.1)
Tumor invasion [N(%)]
T1/T2 4 (13.3) 26 (86.7) 0.453b 13 (43.3) 17 (56.7) 0.616b 29 (96.7) 1 (3.3) 0.560b
T3/T4 11 (11.6) 84 (88.4) 28 (29.5) 67 (70.5) 84 (88.4) 11 (11.6)
Lymph node metastasis [N(%)]
Absent 3 (25) 9 (75.0) 0.193b 8 (66.7) 4 (33.3) 0.024*b 12 (100) 0(0) 0.999b
Present 12 (10.6) 101 (89.4) 33 (29.2) 80 (70.8) 101 (89.4) 12 (10.6)
Distant metastasis [N(%)]
Absent 11 (16.7) 55 (83.3) 0.136b 30 (45.5) 36 (54.5) 0.005*b 62 (93.9) 4 (6.1) 0.258b
Present 4 (6.8) 55 (93.2) 11 (18.6) 48 (81.4) 51 (86.4) 8 (13.6)
EBV infection [N(%)]
Absent 15 (13.3) 98 (86.7) 0.998b 39 (34.5) 74 (65.5) 0.358b
Present 0 (0) 12 (100) 2 (16.7) 10 (83.3)
*Significant difference between groups, p < 0.05. ap value after adjustment for age; bp value after adjustment for age and gender; cNegative samples for H. pylori
and samples with H. pylori infection but without CagA virulence factor; EBV: Epstein-Barr virus; IQR: interquartile range.
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adults with gastritis who were also positive for HP in-
fection and HP CagA+ were older than those without
this pathogen (p = 0.011 and p = 0.039, respectively, T-test;
Table 2).
In tumor samples, patients with HP CagA+ were older
than patients without HP CagA- (p = 0.027, Mann-Whitney
test; Table 3). HP CagA+ was more prevalent in intestinal-
type than diffuse-type GC (p = 0.012; OR = 2.741, 95%
CI 1.252 – 6.001, after adjustment for age and gender;
Table 3). The presence of HP CagA + was also associ-
ated with lymph node metastasis (p = 0.024; OR = 5.611,
95% CI = 1.255 – 25.097, after adjustment for age and
gender) and distal metastasis (p = 0.005; OR 3.299, 95%
CI = 1.441 – 7.556, after adjustment for age and gender;
Table 3).
EBV infection was detected in 0% of normal gastric
mucosa samples, 3.8% of samples from juvenile gastritispatients, 5.1% of samples from adult gastritis patients
and 9.6% of GC patients (Figure 1c and Figure 2). In
the gastric mucosa, we found that 5-15% of cells were
infected. Rates of EBV infection did not differ among
normal gastric mucosa and mucosa from juvenile pa-
tients with gastritis (p > 0.05, Yates correction). More-
over, the frequency of EBV infection in the gastritis of
adults did not differ from that observed in the gastritis
of juvenile patients and GC samples (p > 0.05, after ad-
justment for age and gender). No association between
EBV infection and HP infection or any clinicopatholog-
ical variable was found (p > 0.05, Table 1, 2 and 3).
Although we did not observe a statistically significant
association between the two pathogens, only one EBV-
positive case was found without concomitant HP infec-
tion. This case was an 18-year-old female with no sign
of gastric disease by UE evaluation and mild gastritis by
histopathological analysis.
Figure 2 Detection of EBV by in situ hybridization. Strong
nuclear staining was observed in infected nuclei in a A) mild
gastritis (40x) and B) adult moderate gastritis.
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Infection by HP and EBV occurs most often during child-
hood, and both viruses can synergistically enhance the
alteration of gastric mucosa to chronic gastritis and GC
[6,17,19,25].
Gastritis is more likely to occur in older adults but can
affect people of all ages, including children. Many stud-
ies [26,27] have attempted to understand the develop-
ment of gastritis in children. Souza et al. [28], identified
endoscopic abnormalities in 74% of the children and ad-
olescents studied. Among these, 26% (7/21) had gastritis
as determined by UE. In our study, gastritis was identified
by UE in a larger number of juvenile patients (40/62).
However, finding an apparently normal mucosa by en-
doscopy does not exclude the possibility of pathological
change, as biopsy is required for a definitive determin-
ation. Our results confirm this assertion because in 22
normal endoscopic exams, only 9 showed a normal
histological pattern. In addition, patients with mild
gastritis were younger than patients with moderate or
severe gastritis, perhaps because they had not yet been
exposed to many aggressive agents that can lead to gas-
tritis [6].
In the present study, HP infection was detected in
most of the UE patients and GC samples, although the
techniques used may underestimate the presence of the
bacteria. Other studies in Brazil, such as those by Gatti
et al. [29] and Souza et al. [28], reported the prevalence
of HP infection in juveniles to be 51% and 60%, respect-
ively. These results are consistent with our findings. An
investigation in other developing countries also showed a
similar frequency (61.8%) [30]. In adults, a slightly higher
frequency was found in other studies in Brazilian (88.4%)
[31] and African (70–97%) populations [32]. These num-
bers most likely reflect the social and health conditions ofthe studied populations because infections by HP are
more common in developing countries than in developed
countries [19].
In our study, HP infection was more common in cases
of moderate or severe gastritis than in juveniles with
mild gastritis. Similarly, Álvarez et al. [31] found a
higher frequency of moderate and severe gastritis in pa-
tients infected by HP. Additionally, we observed that the
prevalence of HP, particularly HP CagA+, increased with
age, corroborating previous investigations in populations
from northeastern Brazil, China, and Japan [31-33]. It
has been suggested that the earlier HP infection occurs,
the greater the risk for GC due to chronic inflammatory
reactions to the infection [34]. In the population studied
here, the frequency of infection by HP or HP CagA+ in
GC patients did not differ from that observed in adults
patients with gastritis. However, some studies have
found that the spontaneous disappearance of HP during
malignant transformation of gastric epithelia is possible
[35,36]. Nevertheless, cancer still occurs after successful
eradication of HP; therefore, eradication of HP does not
lead to a significant decrease in the incidence of gastric
cancer [37]. Furthermore, it has been observed that the
eradication of HP must occur before carcinomatous
change develops [38]. This finding highlights the neces-
sity of epidemiological studies to understand the inci-
dence and prevalence of HP in a population and to help
in the development of population-specific strategies to
prevent and control HP.
The prevalence of HP in gastric tumors varies with the
country being analyzed [39]. In Brazil, a previous study
detected this bacteria in 85.7% of gastric tumor samples
[40], which is similar to the frequency observed in our
study (88%). In addition, we observed that the frequency
of HP was 1.5-times greater in GC samples than in ju-
venile gastritis samples, and almost ninety times higher
than in normal gastric mucosa, highlighting a strong as-
sociation between HP and the process of gastric carcino-
genesis. After initial infection by HP, patients develop
acute gastritis. This may resolve spontaneously, but the
majority of cases progress to chronic gastritis [41]. The
clinical outcome of HP infection is determined by the
complex interaction between host factors and bacteria
[42]. CagA is likely the most significant virulence factor
[43] and is strongly associated with the risk for GC [42].
It is known that the basic CagA genotype acquired in
childhood remains throughout life [44].
HP CagA+ strains have been associated with more in-
tense inflammation and greater bacterial density, as well
as progression to gastric atrophy, peptic ulcer and gas-
tric cancer [43]. However, the involvement of HP CagA+
in gastric carcinogenesis in Brazilian individuals is still
controversial. Oliveira et al. [45] found an association
between the presence of CagA with more marked antral
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cinoma (94.23%) in Brazilian adults. In another study of
the Brazilian population, Gatti et al. [29] found a slightly
greater frequency (69%) of CagA+ in patients with
chronic gastritis. However, the authors did not find any
association between CagA+ strains and chronic gastritis,
suggesting that other bacterial factors are involved in
disease genesis. Consistent with this, in our study we did
not find an association between HP CagA+ and the pres-
ence of gastritis. However, HP CagA+ was associated
with poor prognostic variables in GC cancer.
Here, the CagA+ genotype was associated with the age,
histological subtype and metastatic process of GC pa-
tients. Unlike Kuo et al. [46], we found a higher frequency
of CagA+ patients in the older cohort of our Brazilian
population. Moreover, the presence of HP CagA+ was
higher in intestinal-type than in diffuse-type GC. The
transformation in gastric mucosa induced by HP CagA+ is
similar to the alterations that occur in the intestinal-type
of GC [2,47]; thus, finding the highest frequency (84.6%)
of CagA+ in intestinal-type GC is reasonable. Additionally,
the presence of HP CagA+ may induce tumor alterations
that lead to metastasis. Kong et al. [48] observed that HP
stimulates the synthesis of CACUL1 in a gastric tumor
cell line, which in turn promotes the expression of matrix
metalloproteinase 9 and increases invasion and metastasis.
Approximately 7% of our patients presented EBV in-
fection in gastric tissue samples. None of these patients
presented symptoms of mononucleosis. Therefore, EBV
infection in gastric mucosa is not necessarily associated
with infection in lymph nodes or tonsils.
The frequency of infection by EBV in GC (9.6%) was
similar to the frequency previously described in other
populations (approximately 7.3 – 13%) [49-51]. However,
the prevalence of EBV infection in patients with gastritis
(3.8% among juvenile and 5.1% among adults) was re-
duced in comparison to the prevalence reported in the
literature. Ryan et al. [25] found EBV sequences in 83%
(5/6) of adult and 30% (15/50) of pediatric gastritis le-
sions. The low frequency identified in gastric mucosa of
the younger patients may be because the stomach is not
the primary location for B lymphocytes immortalized by
EBV infection. The gastric mucosa does not seem to
possess the necessary homing mechanism for settlement
by these infected lymphocytes [5].
Although our results suggest that EBV is not critical for
the initial steps of gastric mucosal injury in the Brazilian
population, the presence of EBV genomes and their ex-
pression in gastric carcinoma cells raises the possibility
that this virus may contribute to neoplastic transform-
ation. Notably, EBV was found within the malignant cells
in approximately 10% of gastric adenocarcinomas, and
this infection seems to precede malignant transformation
[52]. Additionally, a previous in vitro study reported thatreactive products from HP infection trigger EBV reactiva-
tion in latently infected gastric epithelial cells [53]. Inflam-
matory stress that occurs during the malignization of
gastric cells may lead to infiltration of lymphocytes carry-
ing EBV. This process may increase the possibility of con-
tact with epithelial cells, or it may produce a rich medium
that supports the cytokine-stimulated clonal replication of
EBV-infected epithelial cells [16].
Recently, Cárdenas-Mondragón [54] reported that co-
infection with EBV and HP CagA+ was associated with
the presence of severe gastritis, reveling a critical role
for EBV in gastric mucosal alterations. Here, we did not
find an association between EBV and HP or the presence
of CagA in our gastritis or cancer samples, most likely
due to the low frequency of EBV.
The main limitation of this study is its relatively small
sample size. Therefore, some of the statistical analyses
presented reduced the power to detect significant differ-
ences between groups. Therefore, further investigations
are still necessary to fully understand the roles of EBV and
HP in gastric carcinogenesis in the Brazilian population.Conclusion
Our results strongly suggest that HP is involved in the
pathophysiology of severe gastric lesions and develop-
ment of GC in infected juveniles and adults. Further-
more, the frequency of these pathologies increases with
age. HP CagA+ was associated with greater inflammation
and more advanced stage of cancer. EBV was not the
primary pathogenic factor in our sample. Additionally, a
better understanding of the most prevalent strains of
pathogens, and their associated antigens, will be valuable
for the development of vaccines clinical protocols for
screening and treating infection.Abbreviations
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